Real World Outcomes In Latin-American Patients With Multiple Myeloma Under 40 Years Old

BLOOD(2019)

Cited 4|Views29
No score
Abstract
Background Multiple myeloma (MM) is a heterogeneous disease that is most frequently diagnosed in the elderly. Therefore, data on clinical characteristics and outcomes in the young population are scarce and it is recognized that it remains incurable even in this group of patients. We present here the outcomes of patients under 40 years old cohort in Latin-American countries. On behalf of GELAMM (Grupo de Estudio Latino-Americano de Mieloma Múltiple).
More
Translated text
Key words
multiple myeloma,real world outcomes,latin-american
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined